Galectin-3 predicts short- and long-term outcome in patients undergoing transcatheter aortic valve implantation (TAVI).
Baldenhofer G, Zhang K, Spethmann S, Laule M, Eilers B, Leonhardt F, Sanad W, Dreger H, Sander M, Grubitzsch H, Baumann G, Stangl K, Stangl V, Knebel F.
Baldenhofer G, et al. Among authors: grubitzsch h.
Int J Cardiol. 2014 Dec 20;177(3):912-7. doi: 10.1016/j.ijcard.2014.10.010. Epub 2014 Oct 20.
Int J Cardiol. 2014.
PMID: 25456698